1. Life-Saving Filter Technology Attracts $7.5 Million from Local Investors

    Explore Article Latest Press Releases (May 6 2010)

    Life-Saving Filter Technology Attracts $7.5 Million from Local Investors Banas and Castella have a long and impressive history of product development and commercializing medical devices. In 2003, Banas and his partner in Advanced Bio Prosthetic Surfaces, Dr. Julio Palmaz ( inventor of the balloon expandable stent), licensed a unique NITINOL stent technologies to Cordis, a division of Johnson & Johnson. Xenotope Diagnostics' co-founder and CEO, Castella, licensed worldwide manufacturing and sales rights for a unique rapid-test technology developed by Xenetope to Genzyme Corporation in 2004. Then in 2005, Banas and Castella co-founded CardioSpectra, another medical device company, which they sold to Volcano Corporation in late 2007. "When we saw ... (Read Full Article)

    Comment on Article Mentions:   Cordis   University of Texas Health Science Center   Volcano

1-1 of 1